Dr. Reddys Laboratories Ltd 2013 AR2
The report highlights Dr. Reddy's Laboratories Limited's performance for the fiscal year 2012-13, during which the company achieved a consolidated revenue of –116.3 billion, representing a 20% year-on-year growth. Key developments included the acquisition of OctoPlus N.V. to strengthen its controlled-release technology platform and a strategic alliance with Merck Serono to co-develop biosimilar compounds in oncology. The company also expanded its biosimilars portfolio and continued its commitment to sustainability by investing –251 million in nine environmental management projects and –156 million in 29 energy conservation projects. Additionally, Dr. Reddy's Foundation continued to support social initiatives, creating over 280,000 livelihoods since its inception.
Company: Dr. Reddys Laboratories Ltd
Sector: Health Care
Country: India
Year: 2013
Type: AR2
Pages: 204
Back to company
Dr. Reddys Laboratories Ltd
Annual Report
The report highlights Dr. Reddy's Laboratories Limited's performance for the fiscal year 2012-13, during which the company achieved a consolidated revenue of –116.3 billion, representing a 20% year-on-year growth. Key developments included the acquisition of OctoPlus N.V. to strengthen its controlled-release technology platform and a strategic alliance with Merck Serono to co-develop biosimilar compounds in oncology. The company also expanded its biosimilars portfolio and continued its commitment to sustainability by investing –251 million in nine environmental management projects and –156 million in 29 energy conservation projects. Additionally, Dr. Reddy's Foundation continued to support social initiatives, creating over 280,000 livelihoods since its inception.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2013
Reporting Period
Apr 1, 2012 - Mar 31, 2013
Fiscal Year
2013
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees